The human immunodeficiency virus (HIV1) infection market was valued at USD 20.64 Billion in 2025. The market is expected to grow at a CAGR of 5.20% during the forecast period of 2026-2035, with the values likely to reach USD 34.27 Billion by 2035. The market growth is driven by the increasing availability of antiretroviral therapies and advanced diagnostic tools for HIV1 detection. Growing awareness programs, early intervention strategies, and government initiatives are expected to enhance disease management. Additionally, innovations in long-acting formulations and point-of-care testing devices are projected to support market growth during the forecast period.
Base Year
Historical Period
Forecast Period
The increasing global prevalence of HIV is driving the demand for medications and care services, which significantly contributes to the market growth.
The surge in regulatory approvals of effective medications for HIV-1 treatment is a major market trend.
The rising availability of generic antiretroviral therapies is expected to elevate the market value in the forecast period.
Compound Annual Growth Rate
5.2%
Value in USD Billion
2026-2035
*this image is indicative*
HIV-1 refers to the most common type of HIV (Human Immunodeficiency Virus) in which the virus attacks the immune system by destroying CD4 cells responsible for fighting infections in the body. A person with HIV can develop AIDS (Acquired Immune Deficiency Syndrome) at the most advanced stage of infection. The market for HIV-1 infection is driven by the rising burden of the disease and increasing access to treatment. The introduction of advanced antiretroviral therapies including long acting injectables like cabotegravir and rilpivirine further supports the market growth. Moreover, the increasing availability of cost-effective generic medications and regulatory support from health agencies are anticipated to influence market dynamics.
Increasing Prevalence of Human Immunodeficiency Virus Infection to Drive Market Growth
HIV poses a global public health concern and is estimated to have claimed 42.3 million lives to date. According to the World Health Organization (WHO), approximately 39.9 million individuals were affected by HIV at the end of 2023, with the WHO African Region accounting for 65% of the cases. Further, it was reported that 1.3 million people acquired the infection in 2023, and about 630,000 people died as a result of HIV-related causes. This increasing global prevalence of HIV is driving the demand for HIV medications and care services, which contributes to the market growth.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Market Breakup by Drug Class
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
Market Segmentation Based on Drug Class is Anticipated to Witness Substantial Growth
Based on the drug class, the market is segmented into nucleoside-analog reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and integrase inhibitors, among others. Nucleoside-analog reverse transcriptase inhibitors are one of the most widely used classes of antiretroviral drugs. They inhibit the reverse transcriptase enzyme which is needed for viral replication. Tenofovir disoproxil fumarate (tenofovir DF) is one such medication used in HIV-1 treatment. The availability of generic versions of nucleoside-analog reverse transcriptase inhibitors has made them widely accessible, even in low- and middle-income countries.
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States is a major market for HIV-1 infection due to the high prevalence of HIV and the greater adoption rate of the latest antiretroviral therapies including single tablet formulations and long-acting injectables. Increased government initiatives in the form of public health policies and funding to improve access to HIV care and treatment further fuel the market growth. Further, the availability of affordable generic antiretroviral medications also supports market expansion in the region.
The key features of the market report comprise patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Cipla Limited is a major pharmaceutical company headquartered in Mumbai, India, and is one of the leading players in the market. The company offers antiretroviral drugs in fixed-dose combinations and single-agent formulations. Cipla's antiretroviral medicine Tenvir-EM Tablet , containing a combination of Emtricitabine and Tenofovir disoproxil fumarate, is used for treating HIV infection.
Headquartered in South San Francisco, California, Genentech Inc. is a member of the Roche Group and is involved in HIV-1 research and treatment. Its prescription medicine FUZEON is used in combination with other antiretroviral drugs to treat Human Immunodeficiency Virus-1 (HIV-1) infection.
California-based Gilead Sciences Inc. is a research-based biopharmaceutical company with a prominent presence in the HIV treatment and prevention market. The company has developed 11 commercially available HIV drugs. It is actively involved in advancing the pipeline of next-generation therapeutic treatments.
American pharmaceutical company AbbVie is known for its research and development of novel antiretroviral therapies. Its product NORVIR® (ritonavir) is a well-known treatment for HIV-1 infection.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Boehringer Ingelheim International Gmbh, ViiV Healthcare, Sanofi, and Bristol Myers Squibb.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share